<p>Alyeska Investment Group L.P. 在最近向证券交易委员会（SEC）提交的 13F 表格中披露，在第一季度将其在 Elutia Inc.（NASDAQ:ELUT - 免费报告）的持股比例提高了 310.8%。该基金在此期间额外购买了 2,000,000 股后，持有该公司 2,643,445 股股票。Alyeska Investment Group L.P. 在最近一个季度末持有 Elutia 6.49% 的股份，价值 6,688,000 美元。</p>
<p>其他几家机构投资者也增加或减少了在 ELUT 的持股。OMERS ADMINISTRATION Corp 在第一季度新购入了大约 28,000 美元的 Elutia 股票。Arcus Capital Partners LLC 在第一季度新购入了大约 51,000 美元的 Elutia 股票。Northern Trust Corp 在第四季度将其在 Elutia 的持股比例提高了 30.0%。Northern Trust Corp 目前持有 17,957 股该公司股票，价值 67,000 美元，此前在上个季度额外购买了 4,148 股。Citadel Advisors LLC 在第四季度购买了价值 84,000 美元的 Elutia 新股。最后，Millennium Management LLC 在第四季度将其在 Elutia 的持股比例提高了 16.4%。Millennium Management LLC 目前持有 45,217 股该公司股票，价值 169,000 美元，此前在上个季度额外购买了 6,386 股。目前，74.03% 的股票由机构投资者持有。</p>
<h2>Elutia 股票表现</h2>
<p>ELUT 股票在周五开盘价为 1.88 美元。该公司的市值为 7971 万美元，市盈率为 -1.77，贝塔值为 0.89。Elutia Inc. 的 52 周最低价为 1.61 美元，52 周最高价为 5.12 美元。该股票的 50 日移动平均线为 2.10 美元，200 日移动平均线为 2.25 美元。</p>
<p>Elutia (NASDAQ:ELUT - 获取免费报告) 最近一次发布财报是在 8 月 14 日星期四。该公司报告本季度每股收益为（0.26）美元，低于市场共识预期的（0.17）美元，差距为（0.09）美元。该公司本季度的收入为 626 万美元，而分析师预期为 655 万美元。股票分析师预测 Elutia Inc. 本年度将发布 -1.74 美元的每股收益。</p>
<h2>分析师评级上调与下调</h2>
<p>另外，Lake Street Capital 将 Elutia 的目标价格从 10.00 美元下调至 8.00 美元，并在 5 月 9 日的研究报告中对该公司给予了 “买入” 评级。根据 MarketBeat.com 的数据，两位投资分析师对该股票给予了买入评级，目前该股票的共识评级为 “买入”，平均目标价格为 8.00 美元。</p>
<p><strong>获取我们关于 ELUT 的最新报告</strong></p>
<h2>Elutia 公司简介</h2>
<p>（免费报告）</p>
<p>Elutia Inc. 是一家商业阶段公司，开发和商业化用于神经刺激、伤口护理和乳房重建的药物洗脱生物制品。该公司在三个领域运营：设备保护；女性健康；和心血管。它提供 CanGaroo Envelope，用于容纳心脏植入电子设备，如起搏器和内部除颤器。</p>
<h2>了解更多</h2>
<ul>
<li>我们更看好的五只股票比 Elutia 更好</li>
<li>股票中的缺口上涨意味着什么？如何利用缺口</li>
<li>为什么 DocuSign 在第二季度财报后可能成为 SaaS 价值投资</li>
<li>什么是国债？</li>
<li>Lululemon 股价还有很大的下跌空间</li>
<li>股息之王宝洁在财报后疲软时值得买入</li>
<li>超微公司 2026 年的预测过于保守</li>
</ul>
<p><strong>想看看其他对 ELUT 持有的对冲基金吗？</strong> 访问 HoldingsChannel.com 获取 Elutia Inc.（NASDAQ:ELUT - 免费报告）的最新 13F 文件和内部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9RUxVVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9RUxVVA"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Elutia 吗？</h2>
<p>在考虑 Elutia 之前，你会想听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐，现在就买入，以便在更广泛的市场注意到之前... 而 Elutia 并不在名单上。</p>
<p>虽然 Elutia 目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得买入。</p>
<p>在这里查看这五只股票</p>

ELUT

<p>Alyeska Investment Group L.P. 在第一季度将其在 Elutia Inc. (NASDAQ:ELUT) 的持股增加了 310.8%，额外购买了 2,000,000 股，总持股达到 2,643,445 股，价值 669 万美元。其他机构投资者也调整了在 Elutia 的持仓。该股票开盘价为 1.88 美元，市值为 7971 万美元，市场共识评级为 “买入”，目标价为 8.00 美元。Elutia 报告上个季度每股亏损 0.26 美元，未能达到预期。该公司开发用于各种医疗应用的药物洗脱生物制剂</p>

<p>Alyeska Investment Group L.P. boosted its stake in Elutia Inc. (NASDAQ:ELUT - Free Report) by 310.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,643,445 shares of the company's stock after acquiring an additional 2,000,000 shares during the period. Alyeska Investment Group L.P. owned 6.49% of Elutia worth $6,688,000 at the end of the most recent quarter.</p>
<div class="lb-trans"><p>Alyeska Investment Group L.P. 在最近向证券交易委员会（SEC）提交的 13F 表格中披露，在第一季度将其在 Elutia Inc.（NASDAQ:ELUT - 免费报告）的持股比例提高了 310.8%。该基金在此期间额外购买了 2,000,000 股后，持有该公司 2,643,445 股股票。Alyeska Investment Group L.P. 在最近一个季度末持有 Elutia 6.49% 的股份，价值 6,688,000 美元。</p>
</div><p>Several other institutional investors have also added to or reduced their stakes in ELUT. OMERS ADMINISTRATION Corp acquired a new stake in shares of Elutia during the 1st quarter worth approximately $28,000. Arcus Capital Partners LLC acquired a new position in shares of Elutia during the first quarter worth approximately $51,000. Northern Trust Corp raised its position in Elutia by 30.0% in the 4th quarter. Northern Trust Corp now owns 17,957 shares of the company's stock valued at $67,000 after buying an additional 4,148 shares during the last quarter. Citadel Advisors LLC purchased a new stake in Elutia in the 4th quarter valued at $84,000. Finally, Millennium Management LLC raised its position in Elutia by 16.4% in the 4th quarter. Millennium Management LLC now owns 45,217 shares of the company's stock valued at $169,000 after buying an additional 6,386 shares during the last quarter. 74.03% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>其他几家机构投资者也增加或减少了在 ELUT 的持股。OMERS ADMINISTRATION Corp 在第一季度新购入了大约 28,000 美元的 Elutia 股票。Arcus Capital Partners LLC 在第一季度新购入了大约 51,000 美元的 Elutia 股票。Northern Trust Corp 在第四季度将其在 Elutia 的持股比例提高了 30.0%。Northern Trust Corp 目前持有 17,957 股该公司股票，价值 67,000 美元，此前在上个季度额外购买了 4,148 股。Citadel Advisors LLC 在第四季度购买了价值 84,000 美元的 Elutia 新股。最后，Millennium Management LLC 在第四季度将其在 Elutia 的持股比例提高了 16.4%。Millennium Management LLC 目前持有 45,217 股该公司股票，价值 169,000 美元，此前在上个季度额外购买了 6,386 股。目前，74.03% 的股票由机构投资者持有。</p>
</div><h2>Elutia Stock Performance</h2>
<div class="lb-trans"><h2>Elutia 股票表现</h2>
</div><p>ELUT stock opened at $1.88 on Friday. The company has a market capitalization of $79.71 million, a price-to-earnings ratio of -1.77 and a beta of 0.89. Elutia Inc. has a fifty-two week low of $1.61 and a fifty-two week high of $5.12. The stock has a fifty day moving average of $2.10 and a 200-day moving average of $2.25.</p>
<div class="lb-trans"><p>ELUT 股票在周五开盘价为 1.88 美元。该公司的市值为 7971 万美元，市盈率为 -1.77，贝塔值为 0.89。Elutia Inc. 的 52 周最低价为 1.61 美元，52 周最高价为 5.12 美元。该股票的 50 日移动平均线为 2.10 美元，200 日移动平均线为 2.25 美元。</p>
</div><p>Elutia (NASDAQ:ELUT - Get Free Report) last posted its earnings results on Thursday, August 14th. The company reported ($0.26) EPS for the quarter, missing the consensus estimate of ($0.17) by ($0.09). The company had revenue of $6.26 million during the quarter, compared to analyst estimates of $6.55 million. Equities analysts predict that Elutia Inc. will post -1.74 EPS for the current year.</p>
<div class="lb-trans"><p>Elutia (NASDAQ:ELUT - 获取免费报告) 最近一次发布财报是在 8 月 14 日星期四。该公司报告本季度每股收益为（0.26）美元，低于市场共识预期的（0.17）美元，差距为（0.09）美元。该公司本季度的收入为 626 万美元，而分析师预期为 655 万美元。股票分析师预测 Elutia Inc. 本年度将发布 -1.74 美元的每股收益。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师评级上调与下调</h2>
</div><p>Separately, Lake Street Capital decreased their target price on Elutia from $10.00 to $8.00 and set a &#34;buy&#34; rating for the company in a research report on Friday, May 9th. Two investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock currently has a consensus rating of &#34;Buy&#34; and an average price target of $8.00.</p>
<div class="lb-trans"><p>另外，Lake Street Capital 将 Elutia 的目标价格从 10.00 美元下调至 8.00 美元，并在 5 月 9 日的研究报告中对该公司给予了 “买入” 评级。根据 MarketBeat.com 的数据，两位投资分析师对该股票给予了买入评级，目前该股票的共识评级为 “买入”，平均目标价格为 8.00 美元。</p>
</div><p><strong>Get Our Latest Report on ELUT</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 ELUT 的最新报告</strong></p>
</div><h2>Elutia Profile</h2>
<div class="lb-trans"><h2>Elutia 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Elutia Inc, a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation, wound care, and breast reconstruction in the United States. The company operates in three segments: Device Protection; Women's Health; and Cardiovascular. It offers CanGaroo Envelope, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators.</p>
<div class="lb-trans"><p>Elutia Inc. 是一家商业阶段公司，开发和商业化用于神经刺激、伤口护理和乳房重建的药物洗脱生物制品。该公司在三个领域运营：设备保护；女性健康；和心血管。它提供 CanGaroo Envelope，用于容纳心脏植入电子设备，如起搏器和内部除颤器。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Elutia</li>
<li>What Does a Gap Up Mean in Stocks? How to Play the Gap</li>
<li>Why DocuSign Could Be a SaaS Value Play After Q2 Earnings</li>
<li>What Are Treasury Bonds?</li>
<li>Lululemon Share Price Has Plenty of Room Left to Fall</li>
<li>Dividend King Proctor &amp; Gamble Is A Buy On Post-Earnings Weakness</li>
<li>Advanced Micro Devices' 2026 Forecasts Are Way Too Low</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 Elutia 更好</li>
<li>股票中的缺口上涨意味着什么？如何利用缺口</li>
<li>为什么 DocuSign 在第二季度财报后可能成为 SaaS 价值投资</li>
<li>什么是国债？</li>
<li>Lululemon 股价还有很大的下跌空间</li>
<li>股息之王宝洁在财报后疲软时值得买入</li>
<li>超微公司 2026 年的预测过于保守</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding ELUT?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elutia Inc. (NASDAQ:ELUT - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对 ELUT 持有的对冲基金吗？</strong> 访问 HoldingsChannel.com 获取 Elutia Inc.（NASDAQ:ELUT - 免费报告）的最新 13F 文件和内部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9RUxVVA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=ELUT"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Elutia Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Elutia 吗？</h2>
</div><p>Before you consider Elutia, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Elutia 之前，你会想听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elutia wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐，现在就买入，以便在更广泛的市场注意到之前... 而 Elutia 并不在名单上。</p>
</div><p>While Elutia currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Elutia 目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得买入。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Alyeska 投资集团 L.P.购入了 Elutia 公司 2,000,000 股股票，股票代码为$ELUT